Pharma

AstraZeneca Sells Former Blockbuster Cholesterol Drug Crestor for $320 Million

AstraZeneca Sells Former Blockbuster Cholesterol Drug Crestor for $320 Million

Edited by Nirmalya Sen | Tuesday December 01, 2020

British drug major sold brand drug to German pharma company Gruenenthal

Dr Reddy's Isolates Data Centre Services After Cyberattack, Shares Fall 4%

Dr Reddy's Isolates Data Centre Services After Cyberattack, Shares Fall 4%

Edited by Sandeep Singh (with inputs from agencies) | Thursday October 22, 2020

Cyber-Attack: Dr Reddy's Labs said on Thursday it had isolated all its data center services as a preventive measure following a cyber-attack.

Dr Reddy's Gains On Nod To Hold Trials For Russia's COVID Vaccine In India

Dr Reddy's Gains On Nod To Hold Trials For Russia's COVID Vaccine In India

Edited by Sandeep Singh (with inputs from agencies) | Monday October 19, 2020

Dr Reddy's Share Price: The stock rose by Rs 131.15 to Rs 5,213.50 apiece on the BSE during the session, having begun the day stronger at Rs 5,202.00 compared to its previous close of Rs 5,082.35.

Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US

Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US

Edited by Sandeep Singh | Friday September 18, 2020

The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.

Cipla Hits Record High After Strong June Quarter Earnings

Cipla Hits Record High After Strong June Quarter Earnings

Edited by Sandeep Singh (with inputs from agencies) | Monday August 10, 2020

Cipla Share Price: By 11:22 am, 6.88 lakh Cipla shares had changed hands on the BSE, as against an average of 3.49 lakh over the past two weeks.

Cipla June Quarter Profit Jumps 21%

Cipla June Quarter Profit Jumps 21%

Edited by Sandeep Singh | Friday August 07, 2020

Cipla's revenue from the pharmaceuticals segment rose 7.73 per cent to Rs 4,266.09 crore.

Serum Institute To Partner With Gates Foundation To Make COVID-19 Vaccine

Serum Institute To Partner With Gates Foundation To Make COVID-19 Vaccine

Reuters | Friday August 07, 2020

The institute said on Friday it will get funding to support manufacturing for candidate vaccines from AstraZeneca and Novavax.

Zydus Cadila's COVID-19 Vaccine Candidate Found Safe In Early-Stage Human Trial

Zydus Cadila's COVID-19 Vaccine Candidate Found Safe In Early-Stage Human Trial

Reuters | Wednesday August 05, 2020

Zydus plans to complete late-stage trials for ZyCoV-D by February or March and could produce up to 100 million doses a year initially.

Wockhardt To Supply COVID-19 Vaccines To UK

Wockhardt To Supply COVID-19 Vaccines To UK

Reuters | Monday August 03, 2020, Bengaluru

AstraZeneca has indicated it would need 30 million fill-and-finish doses of their vaccine candidate, which the company intends to supply in the next few months, Wockhardt's chairman said.

Sun Pharma Acquires Canada's Aquinox Pharma For $8.2 Million, Shares Gain

Sun Pharma Acquires Canada's Aquinox Pharma For $8.2 Million, Shares Gain

Edited by Sandeep Singh | Wednesday July 29, 2020

Aquinox Pharmaceuticals is a research and development company focused on pharmaceutical products for the purpose of their commercialisation, Sun Pharma said.

Cipla Gets Regulatory Nod To Sell COVID-19 Drug

Cipla Gets Regulatory Nod To Sell COVID-19 Drug

Reuters | Saturday July 25, 2020, Bengaluru

Cipla said it would launch favipiravir as "Ciplenza" in the first week of August, priced at Rs 68 (91 cents) per 200 mg tablet.

Glenmark Defends Price Of Its COVID-19 Drug Favipiravir Version

Glenmark Defends Price Of Its COVID-19 Drug Favipiravir Version

Reuters | Tuesday July 21, 2020

Glenmark denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.

Biocon Gets Regulatory Nod To Use Drug Itolizumab On COVID-19 Patients

Biocon Gets Regulatory Nod To Use Drug Itolizumab On COVID-19 Patients

Reuters | Sunday July 12, 2020, New Delhi

The drug, which is also used to cure the skin disease psoriasis, was cleared by the Drug Controller General of India (DCGI) for usage in the country.

Cipla Set To Undercut Rivals With Generic Remdesivir: Report

Cipla Set To Undercut Rivals With Generic Remdesivir: Report

Reuters | Wednesday July 08, 2020

Sources said the first batch of 10,000 vials had been printed with a price of Rs 4,000, Rs 800 below the cheapest option, launched by European competitor Mylan this week.

Piramal Enterprises Shares Jump After US-Based Carlyle Buys Stake In Pharma Unit

Piramal Enterprises Shares Jump After US-Based Carlyle Buys Stake In Pharma Unit

Edited by Sandeep Singh (with inputs from agencies) | Monday June 29, 2020

Piramal Pharma Share Price: Piramal Enterprises shares rose to as high as Rs 1,387.55 apiece on the BSE during the session.

1234...5